Literature DB >> 8071839

Dopamine D2 and D3 receptors inhibit dopamine release.

L Tang1, R D Todd, K L O'Malley.   

Abstract

D2-like dopamine receptors are thought to control presynaptic dopamine synthesis and release. Because these receptors comprise a family which includes D2, D3 and D4 dopamine receptors, the question arises as to which subtype performs what role(s). To investigate the potential autoreceptor roles of these proteins, D2, D3 and D4 receptors were transfected into a mesencephalic clonal cell line which synthesizes and releases dopamine. Here we report that stimulation of transfected D2 and D3 receptors, but not D4 receptors, inhibits dopamine release from this dopaminergic cell line. This is the first report of a functional role for D3 receptors and establishes these cell lines as a convenient in vitro model system to study signal transduction mechanisms associated with autoreceptor function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071839

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  25 in total

1.  Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging.

Authors:  Yin-Ching I Chen; Ji-Kyung Choi; Susan L Andersen; Bruce R Rosen; Bruce G Jenkins
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

Review 2.  GPCR functional selectivity has therapeutic impact.

Authors:  Richard B Mailman
Journal:  Trends Pharmacol Sci       Date:  2007-07-13       Impact factor: 14.819

Review 3.  Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition.

Authors:  R D Todd; J S Perlmutter
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

Review 4.  A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

5.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; David Scheibal; Emily Hahn; Sharon Shiraga; Eleanor Zamora-Paja; Judah Farahi; Sanjaya Saxena; Edythe D London; James T McCracken
Journal:  Arch Gen Psychiatry       Date:  2006-07

6.  FosB is essential for the enhancement of stress tolerance and antagonizes locomotor sensitization by ΔFosB.

Authors:  Yoshinori N Ohnishi; Yoko H Ohnishi; Masaaki Hokama; Hiroko Nomaru; Katsuhisa Yamazaki; Yohei Tominaga; Kunihiko Sakumi; Eric J Nestler; Yusaku Nakabeppu
Journal:  Biol Psychiatry       Date:  2011-06-15       Impact factor: 13.382

7.  Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo.

Authors:  J M Tepper; B C Sun; L P Martin; I Creese
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

8.  Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists.

Authors:  Ji-Kyung Choi; Joseph B Mandeville; Y Iris Chen; Peter Grundt; Susanta K Sarkar; Amy H Newman; Bruce G Jenkins
Journal:  Psychopharmacology (Berl)       Date:  2010-07-14       Impact factor: 4.530

9.  Chronic Social Isolation Stress during Peri-Adolescence Alters Presynaptic Dopamine Terminal Dynamics via Augmentation in Accumbal Dopamine Availability.

Authors:  Anushree N Karkhanis; Amy C Leach; Jordan T Yorgason; Ayse Uneri; Samuel Barth; Farr Niere; Nancy J Alexander; Jeffrey L Weiner; Brian A McCool; Kimberly F Raab-Graham; Mark J Ferris; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2018-10-16       Impact factor: 4.418

10.  Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells).

Authors:  Guihua Cao; Alice Gardner; Thomas C Westfall
Journal:  Biochem Pharmacol       Date:  2007-01-07       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.